Suchergebnisse - "Antirheumatic Agents"

PubPharm (5.319)

41

Exosomal microRNAs as biomarkers for viral replication in tofacitinib-treated rheumatoid arthritis patients with hepatitis C

enthalten in: Scientific reports | 2024

von Liao, T. | Chen, I. | Chen, H. | +4

42

Screening, prophylaxis, and challenges : Tumor necrosis factor inhibitors and latent tuberculosis infection nexus in rheumatology

enthalten in: International journal of rheumatic diseases | 2024

von Su, K. | Li, X. | Jiang, Z. | +1

43

Comorbidities in the Spondyloarthritis GISEA Cohort : an average treatment effect analysis on patients treated with bDMARDs

enthalten in: Clinical and experimental rheumatology | 2024

von Scagnellato, L. | Collesei, A. | Doria, A. | +46

44

Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis

enthalten in: Clinical reviews in allergy & immunology | 2023

von Luciano, N. | Barone, E. | Timilsina, S. | +2

45

Long-term golimumab persistence : Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Clinical rheumatology | 2023

von Weinstein, C. | Meehan, A. | Lin, J. | +2

46

Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis

enthalten in: Yonsei medical journal | 2023

von Kwon, O. | Park, M.

47

Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor : A narrative review

enthalten in: Modern rheumatology | 2023

von Caporali, R. | Conti, F. | Iannone, F.

48

Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis : a cohort study of 14 778 patients from the French health insurance database (SNDS)

enthalten in: RMD open | 2023

von Pina Vegas, L. | Penso, L. | Sbidian, E. | +1

ErratumIn: RMD Open. 2024 Jan 12;10(1):. - PMID 38216291

49

Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis

enthalten in: Arthritis care & research | 2023

von Merjanah, S. | Liew, J. | Bihn, J. | +4

50

Are TNF inhibitors still the agent of choice for RA?

enthalten in: Nature reviews. Rheumatology | 2023

von Taylor, P.